Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the.............
Analog
Devices, Inc announced a strategic alliance to
accelerate the development of a fully digitized biological world. This partnership will
bridge ADI’s expertise in engineering for analog and digital semiconductors
with Flagship Pioneering’s expertise in applied biology to foster the discovery
of biological insights, new and enhanced measurements, diagnostics, and novel
interventions. The partnership represents the opportunity to create breakthrough
solutions for human health and sustainability.
Specifically, the partnership will
leverage Flagship Pioneering’s unique innovation process and ADI’s cutting
edge semiconductor technologies, signal processing portfolio and physical world
domain expertise to unlock deeply disruptive solutions and create new companies
in the digital biology space. Initial areas of focus will include bioelectronic
platforms, regenerative agriculture, novel applications of AI/ML, and
preemptive health and medicine. Potential advancements may further drive
next-generation protein sequencing, multiomics, early disease diagnostics,
transformation of large biological information to actionable digital data, drug
design and optimization, and more. This partnership is the latest in Flagship
Pioneering’s Enabling Technologies Initiative, which is focused on the development of new
therapeutic modalities by enabling and powering advanced technologies.
“At its core,
ADI exists to accelerate breakthroughs that enrich lives and the world around
us,” said Vincent Roche, CEO and Chair at ADI. “Innovative technology has the
potential to enable better and more proactive care. We expect our digital
biology partnership with Flagship Pioneering will put the Intelligent Edge at
the center of innovating data-informed health solutions for some of today's
biggest challenges.”
“Fueled by technological leaps and deep
biological understanding, we have entered a new era of biomedical and life
science innovation, enabling ever-greater advances to improve the health of
humans and the planet,” said Noubar Afeyan, Ph.D., Founder and CEO of Flagship
Pioneering. “Flagship and ADI have a shared
ambition and complementary strengths to accelerate the development of a fully
digitized biological world that harnesses nature’s intelligence to create
solutions for preventative and therapeutic medicines, regenerative agriculture,
and threats from climate change.”
The partnership
will be fueled by Flagship Pioneering’s origination process for pioneering and
scaling novel technologies and/or biological insights that have led to new
types of therapeutic modalities such as mRNA, tRNA, and epigenetic controllers.
ADI’s current applications of sensor technologies, microfabrication
technologies, and automation for healthcare including diagnostics, imaging,
therapeutic devices, and continuous monitoring will underpin the combinatorial
innovation driven through this engagement. Flagship Pioneering’s
scientist-entrepreneurs will partner with ADI’s scientists and engineers to
conceive and create new bioplatforms that build on capabilities to bridge
biology and technology, advancing novel human health and sustainability
innovations.
Leave A Comment